| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.348 | 34.929 | 68.188 | 120.064 | 174.758 | 164.079 | 203.436 | 223.298 | 225.126 | 260.419 |
| Total Income - EUR | 13.348 | 34.929 | 68.711 | 123.559 | 178.771 | 168.660 | 207.289 | 227.168 | 230.018 | 266.539 |
| Total Expenses - EUR | 12.074 | 29.359 | 52.225 | 96.575 | 129.098 | 119.939 | 136.343 | 152.800 | 160.085 | 171.795 |
| Gross Profit/Loss - EUR | 1.274 | 5.570 | 16.485 | 26.983 | 49.673 | 48.721 | 70.946 | 74.368 | 69.933 | 94.745 |
| Net Profit/Loss - EUR | 878 | 4.522 | 14.440 | 25.309 | 47.830 | 47.311 | 69.083 | 72.046 | 67.570 | 80.103 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oftaderm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 39.740 | 40.335 | 63.896 | 128.692 | 87.295 | 66.166 | 102.627 | 107.406 | 141.950 | 226.634 |
| Current Assets | 1.927 | 5.101 | 8.336 | 39.380 | 42.905 | 64.403 | 81.186 | 84.013 | 66.246 | 53.791 |
| Inventories | 1.692 | 5.074 | 6.772 | 30.831 | 31.944 | 43.876 | 55.251 | 57.210 | 53.273 | 51.382 |
| Receivables | 0 | 0 | 0 | 6.447 | 8.165 | 8.010 | 7.833 | 0 | 4.976 | 1.402 |
| Cash | 235 | 26 | 1.564 | 2.102 | 2.796 | 12.516 | 18.102 | 26.804 | 7.996 | 1.007 |
| Shareholders Funds | 923 | 5.436 | 19.783 | 44.736 | 52.482 | 57.233 | 121.855 | 72.111 | 139.462 | 218.643 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 40.744 | 40.000 | 30.529 | 96.389 | 55.306 | 55.285 | 48.158 | 109.327 | 51.686 | 50.949 |
| Income in Advance | 0 | 0 | 21.920 | 26.947 | 22.412 | 18.050 | 13.800 | 9.981 | 17.048 | 10.832 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Oftaderm S.r.l.